US senators from both sides of the aisle have issued a letter calling for input on the 340B Drug Pricing Program from stakeholders. The program provides eligible care centers with reduced prices on certain prescription drugs. Some stakeholders have complained about a lack of clarity and transparency from the program.
According to Victoria Bailey, “The Health Resources and Services Administration (HRSA), which administers the 340B program, issued guidance over ten years ago allowing covered entities to dispense 340B drugs through contract pharmacies, as many entities do not have in-house pharmacies. However, the current 340B statute does not say the same, creating ambiguity in the treatment of drugs dispensed through contract pharmacies.”
To read more, click here.
(Source: Revcycle Intelligence, June 20th, 2023)